Moderna raises annual revenue forecast amid strong COVID vaccine demand overseas On Friday, Moderna upgraded its full-year sales outlook after strong international demand for its COVID-19 vaccine and collaboration revenues enabled the biotech to achieve profitability in the third quarter. The. ..



